Have you always wanted to work with big pharma players, but couldn’t get access to them? Can your technologies/services help patients suffering from Multiple Sclerosis, Adult ADHD or Chronic Kidney Disease? And finally, are you up for a challenge? Then we have an opportunity for you.
The EIT Health Programme ‘Start-ups Meet Pharma’ is a challenge-based acceleration programme connecting key pharma partners in Europe with startups at the forefront of technology innovation.
In 2021, five pharma companies (Takeda, Abbot, Merck, Amgen and AstraZeneca) will open their innovation departments and explore collaborations with startups through the ‘Start-ups Meet Pharma’ programme. Past editions of the programme have ended with many NDAs signed, clinical trials kicked-off and collaborative projects in the works.
Challenges for 2021
- Facilitate patients’ identification/screening in clinical trials (in collaboration with Amgen)
- Integrated care for chronic kidney disease patients (in collaboration with AstraZeneca)
- Digital remote monitoring and support solutions for patients living with multiple sclerosis (in collaboration with Merck)
- Digital and personalised health for adult ADHD (in collaboration with Takeda)
- Tools for monitoring loss of muscle, strength and/or physical function, to manage sarcopenia and frailty in the elderly (in collaboration with Abbott)
A detailed description of the challenges is available for download here.
- Collaboration with top experts in your field and development support from a major pharmaceutical company
- A tailored training programme designed to help your startup achieve success
- One-on-one access to our pharma sponsors, allowing you to develop relationships with key stakeholders and industry leaders
Programme structure: Four different modules with the objective to train and prepare startups to discuss collaboration opportunities with pharma companies from April to November 2021.
Programme location: Hybrid, with online sessions and sessions in Heidelberg, Germany and other locations in Europe.
Programme cost: Free of charge.